Cyclo (RLsKDK) - CAS 1975145-82-4

Cyclo (RLsKDK) (BK-1361) serves as a targeted inhibitor of the metalloproteinase ADAM8, demonstrating efficacy with an IC50 value of 182 nM. This compound shows promise for use in the treatment of inflammatory diseases and cancer, highlighting its potential therapeutic applications.

MMP

Proteases/Proteasome

1975059

C31H57N11O9

727.85

C(CCNC(=N)N)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@H](CC(C)C)NC1=O

-20°C

Ice Packs

Peptide